SVRA Savara Inc. Stock Quote

SVRA [NASD]

Index	-	P/E	-	EPS (ttm)	-1.34	Insider Own	0.50%	Shs Outstand	60.29M	Perf Week	-14.56%
Market Cap	100.94M	Forward P/E	-	EPS next Y	-0.45	Insider Trans	11.12%	Shs Float	45.24M	Perf Month	15.03%
Income	-67.60M	PEG	-	EPS next Q	-0.10	Inst Own	46.00%	Short Float	1.62%	Perf Quarter	32.33%
Sales	0.30M	P/S	336.45	EPS this Y	-5.70%	Inst Trans	10.29%	Short Ratio	1.34	Perf Half Y	23.94%
Book/sh	1.27	P/B	1.39	EPS next Y	37.50%	ROA	-56.20%	Target Price	2.67	Perf Year	-28.16%
Cash/sh	1.64	P/C	1.07	EPS next 5Y	-	ROE	-77.40%	52W Range	1.00 - 3.17	Perf YTD	53.04%
Dividend	-	P/FCF	-	EPS past 5Y	34.70%	ROI	-	52W High	-44.48%	Beta	1.08
Dividend %	-	Quick Ratio	12.60	Sales past 5Y	-	Gross Margin	-	52W Low	76.85%	ATR	0.20
Employees	36	Current Ratio	12.60	Sales Q/Q	-	Oper. Margin	-	RSI (14)	50.87	Volatility	11.20% 11.89%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	38.30%	Profit Margin	-	Rel Volume	0.61	Prev Close	1.82
Shortable	Yes	LT Debt/Eq	0.33	Earnings	-	Payout	-	Avg Volume	548.07K	Price	1.76
Recom	2.00	SMA20	-2.57%	SMA50	12.17%	SMA200	5.03%	Volume	335,044	Change	-3.30%

Jun-13-19

Reiterated

H.C. Wainwright

Buy

$22 → $6

Jun-13-19

Downgrade

Ladenburg Thalmann

Buy → Neutral

$21 → $3

Jun-13-19

Downgrade

JMP Securities

Mkt Outperform → Mkt Perform

Aug-13-18

Resumed

ROTH Capital

Neutral

$12

Jan-03-18

Initiated

Ladenburg Thalmann

Buy

$35

Sep-27-17

Resumed

ROTH Capital

Buy

$40

Sep-22-17

Initiated

Jefferies

Buy

$20

Sep-11-17

Initiated

JMP Securities

Mkt Outperform

$20

Feb-05-21 08:32AM	Is the Options Market Predicting a Spike in Savara (SVRA) Stock? Zacks
Jan-21-21 04:24AM	Is Savara (NASDAQ:SVRA) Using Too Much Debt? Simply Wall St.
Dec-10-20 12:02PM	Is SVRA A Good Stock To Buy Now? Insider Monkey -13.79%
08:05AM	Savara Provides Pipeline and Business Update Business Wire
Nov-24-20 04:15PM	Savara Announces Participation in Fireside Chats at Two Upcoming Virtual Investor Healthcare Conferences Business Wire +6.15%
Nov-11-20 04:05PM	Savara to Present at the Jefferies Virtual London Healthcare Conference Business Wire
Nov-05-20 04:20PM	Savara Reports Third Quarter 2020 Financial Results and Provides Business Update Business Wire
Sep-11-20 08:05AM	Savara Announces Senior Management Changes Business Wire -11.85%
Sep-09-20 04:05PM	Savara to Present at the 22nd Annual H.C. Wainwright Annual Investment Conference Being Held Virtually Business Wire
Sep-08-20 08:05AM	Savara Announces New England Journal of Medicine (NEJM) Publication of IMPALA Study Results Business Wire +7.20%
Sep-04-20 12:47PM	Savara to Stop Study on Molgradex for NTM Lung Infection Zacks -8.76%
07:28AM	The Daily Biotech Pulse: AbbVie In-licenses I-Mab's Cancer Drug, Savara Pulls The Plug On Cystic Fibrosis Study Benzinga
Sep-03-20 04:05PM	Savara to Discontinue Exploratory ENCORE Study Evaluating Molgradex for the Treatment of NTM Lung Infection in People Living With Cystic Fibrosis (CF) Business Wire
Aug-25-20 07:42AM	Savara Enters Oversold Territory Zacks
Aug-06-20 04:02PM	Savara Reports Second Quarter 2020 Financial Results and Provides Business Update Business Wire
Aug-05-20 08:05AM	Savara to Present at the 40th Annual Canaccord Genuity Global Growth Conference to be Held Virtually Business Wire
Jul-30-20 08:05AM	Savara to Report Second Quarter 2020 Financial Results and Provide Business Update Business Wire
Jul-05-20 06:11PM	Were Hedge Funds Right About Souring On Savara, Inc. (SVRA)? Insider Monkey
May-27-20 04:05PM	Savara to Present at the Jefferies Virtual Healthcare Conference Business Wire
May-08-20 08:05AM	Savara Announces Change of Date for 2020 Annual Meeting of Stockholders Business Wire -7.84%
May-07-20 04:05PM	Savara Reports First Quarter 2020 Financial Results and Provides Business Update Business Wire +5.81%
Apr-30-20 04:05PM	Savara to Report First Quarter 2020 Financial Results and Provide Business Update Business Wire -5.86%
Apr-15-20 11:26AM	Are Insiders Buying Savara Inc. (NASDAQ:SVRA) Stock? Simply Wall St.
Apr-02-20 04:05PM	Savara Obtains Global Rights to Develop and Commercialize Apulmiq Business Wire -7.00%
Mar-30-20 04:05PM	Savara Provides Business Update in Response to COVID-19 Pandemic Business Wire +9.30%
Mar-23-20 07:53AM	Savara Sees Hammer Chart Pattern: Time to Buy? Zacks
Mar-12-20 04:05PM	Savara Reports Fourth Quarter / Year-End 2019 Financial Results and Provides Business Update Business Wire +8.05%
02:30PM	Savara, Inc. to Host Earnings Call ACCESSWIRE
Mar-11-20 09:23AM	Is a Surprise Coming for Savara (SVRA) This Earnings Season? Zacks -7.45%
Mar-05-20 08:05AM	Savara to Report Fourth Quarter/Year-End 2019 Financial Results and Provide Business Update Business Wire
Jan-16-20 11:21AM	Is Savara Inc. (NASDAQ:SVRA) A Volatile Stock? Simply Wall St.
Jan-06-20 09:14AM	In the money Jan. 6: Drug, burger makers report multimillion-dollar fundings American City Business Journals -14.74%
Jan-02-20 09:30AM	Are Options Traders Betting on a Big Move in Savara (SVRA) Stock? Zacks -8.93%
Dec-30-19 08:05AM	Savara Granted Breakthrough Therapy Designation for Molgradex for the Treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Business Wire +183.82%
Dec-20-19 11:51AM	Savara Announces Private Placement of $26.8 Million, With Total Potential Proceeds of $75.0 Million Business Wire +7.43%
Dec-19-19 04:18PM	Is Savara, Inc. (SVRA) A Good Stock To Buy? Insider Monkey
Dec-03-19 04:05PM	Savara Announces the Appointment of Dr. An van Es-Johansson to Board of Directors Business Wire
11:17AM	2 Falling Knives for Investors to Consider GuruFocus.com
Nov-27-19 04:05PM	Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) Business Wire
Nov-26-19 04:05PM	Savaras COO and CMO to Present at the Evercore ISI 2nd Annual HealthCONx Conference Business Wire
Nov-18-19 08:05AM	Savara Appoints Badrul Chowdhury, M.D., Ph.D as Chief Medical Officer Business Wire +21.07%
Nov-15-19 02:45PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Savara Inc. - SVRA ACCESSWIRE
Nov-13-19 02:45PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Savara Inc. SVRA GlobeNewswire
Nov-12-19 04:05PM	Savara to Present at the Stifel 2019 Healthcare Conference Business Wire -6.71%
Nov-11-19 06:15PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Savara Inc. - SVRA ACCESSWIRE
Nov-07-19 05:50PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Savara Inc. - SVRA GlobeNewswire
04:05PM	Savara Reports Third Quarter 2019 Financial Results and Provides Business Update Business Wire
Oct-31-19 04:05PM	Savara to Report Third Quarter 2019 Financial Results and Provide Business Update Business Wire
Oct-17-19 02:45PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Savara Inc. - SVRA ACCESSWIRE
Oct-15-19 12:42PM	Have Insiders Been Buying Savara Inc. (NASDAQ:SVRA) Shares? Simply Wall St. +6.08%
Oct-11-19 07:15PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Savara Inc. - SVRA ACCESSWIRE
Oct-07-19 07:30PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Savara Inc. - SVRA ACCESSWIRE
Oct-03-19 11:00AM	Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Savara Inc. (SVRA) ACCESSWIRE
10:18AM	Company News For Oct 3, 2019 Zacks
Oct-02-19 06:00PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Savara Inc. SVRA GlobeNewswire -58.47%
08:02AM	Savara Announces FDA Response From Type C Meeting on Molgradex for aPAP Development Program Business Wire
Sep-18-19 04:15PM	Savara to Present Comprehensive Data From Pivotal Phase 3 IMPALA Study at 2019 ERS Business Wire
Sep-02-19 11:39AM	Mangrove Partners Return, AUM, and Holdings Insider Monkey
Aug-08-19 04:02PM	Savara Reports Second Quarter 2019 Financial Results and Provides Business Update Business Wire
Jul-31-19 08:02AM	Savara to Present at the 39th Annual Canaccord Genuity Global Growth Conference Business Wire
Jul-15-19 03:49PM	Some Savara (NASDAQ:SVRA) Shareholders Have Taken A Painful 79% Share Price Drop Simply Wall St.
Jun-25-19 08:52PM	Hedge Funds Have Never Been More Bullish On Savara, Inc. (SVRA) Insider Monkey -5.06%
Jun-20-19 09:45AM	The Zacks Analyst Blog Highlights: Amgen, Alexion, Regeneron, Allergan and Savara Zacks
Jun-19-19 10:29AM	Biotech Stock Roundup: Amgen Gets FDA Nod for Kanjinti, Regeneron Presents Data Zacks +13.87%
Jun-13-19 04:02PM	Savara to Present at the JMP Securities Life Sciences Conference Business Wire -75.21%
12:55PM	Savara Plunges After Lung Disease Drug Fails Phase 3 Trial TheStreet.com
12:33PM	Here's Why Savara Pharmaceuticals Collapsed Today Motley Fool
09:50AM	Savara Plunges on Failure of Late-Stage Study on Molgradex Zacks
Jun-12-19 05:48PM	Savara Shares Slammed on Failed Phase 3 Drug Study TheStreet.com
04:41PM	Savara stock plummets 75% after drug study fails to hit target MarketWatch
04:02PM	Savara Announces Results of IMPALA, a Phase 3 Study of Molgradex for the Treatment of Autoimmune Alveolar Pulmonary Proteinosis (aPAP) Business Wire
Jun-10-19 09:03AM	Implied Volatility Surging for Savara (SVRA) Stock Options Zacks +8.88%
May-17-19 12:20PM	Savara Inc. (SVRA) Q1 2019 Earnings Call Transcript Motley Fool
May-16-19 11:17AM	Savara Inc. (NASDAQ:SVRA) Is Expected To Breakeven Simply Wall St.
May-15-19 09:00AM	Savara Inc (SVRA) Upgraded to Buy: Here's Why Zacks
May-09-19 04:02PM	Savara Reports First Quarter 2019 Financial Results and Provides Business Update Business Wire
May-06-19 08:02AM	Savara Announces Molgradex Received Fast Track Designation by FDA for Treatment of Autoimmune Pulmonary Alveolar Proteinosis Business Wire
May-02-19 08:02AM	Savara to Report First Quarter 2019 Financial Results and Provide Business Update Business Wire
Apr-09-19 09:00AM	Savara Inc (SVRA) Upgraded to Buy: Here's Why Zacks
Apr-02-19 08:00AM	Savara to Present at the H.C. Wainwright Global Life Sciences Conference in London ACCESSWIRE +6.46%
Apr-01-19 08:00AM	Savara Initiates Phase 2a Clinical Study of Molgradex for the Treatment of NTM Lung Infection in People Living with Cystic Fibrosis ACCESSWIRE +7.19%
Mar-13-19 08:52PM	Savara Inc. (SVRA) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:02PM	Savara Reports Fourth Quarter And Full Year 2018 Financial Results And Provides Business Update ACCESSWIRE
Mar-12-19 03:18PM	Did Savara Inc. (NASDAQ:SVRA) Insiders Buy Up More Shares? Simply Wall St. +5.47%
Mar-06-19 08:00AM	Savara To Report Q4/Year-End 2018 Financial Results And Business Update On March 13, 2019 ACCESSWIRE -9.09%
Mar-04-19 08:00AM	Savara to Present at the 39th Annual Cowen and Company Healthcare Conference ACCESSWIRE
Feb-06-19 08:00AM	Savara Provides Update on IMPALA and AVAIL Pivotal Clinical Studies GlobeNewswire
Jan-16-19 09:29AM	Could The Savara Inc. (NASDAQ:SVRA) Ownership Structure Tell Us Something Useful? Simply Wall St.
Dec-21-18 11:18PM	Savara, Inc. (SVRA)Hedge Funds Are Snapping Up Insider Monkey
Dec-19-18 08:00AM	Savara Announces Interim Results for OPTIMA Clinical Study of Molgradex for the Treatment of NTM GlobeNewswire -9.14%
Nov-16-18 08:00AM	Savara to Present at the Evercore ISI HealthCONx Conference on Tuesday, November 27th GlobeNewswire
Nov-07-18 04:02PM	Savara Reports Third Quarter 2018 Financial Results and Provides Business Update GlobeNewswire
Nov-01-18 08:00AM	Savara to Host Third Quarter 2018 Financial Results and Business Update Conference Call on November 7, 2018 GlobeNewswire
Oct-31-18 08:00AM	Savara Completes Enrollment in Molgradex OPTIMA Clinical Study for the Treatment of NTM GlobeNewswire
Oct-15-18 02:09PM	A Look At The Intrinsic Value Of Savara Inc (NASDAQ:SVRA) Simply Wall St.
08:00AM	Savara Completes Enrollment in Pivotal Molgradex Impala Clinical Study for the Treatment of aPAP GlobeNewswire
Sep-27-18 08:00AM	Savara Provides Enrollment Update on Molgradex Impala and OPTIMA Clinical Studies and Reaffirms Guidance for Topline Data GlobeNewswire
Aug-09-18 04:03PM	Savara Reports Second Quarter 2018 Financial Results and Provides Positive Business Update GlobeNewswire
03:30PM	Savara, Inc. to Host Earnings Call ACCESSWIRE
Aug-02-18 08:00AM	Savara to Host Second Quarter 2018 Financial Results and Business Update Conference Call on Thursday, August 9, 2018 GlobeNewswire

Savara Inc. operates as an orphan lung disease company. Its lead product candidate includes Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis; Phase IIa development stage for treating nontuberculous mycobacterial (NTM) lung infection; and in Phase IIa development stage for the treatment of NTM lung infection in people living with cystic fibrosis. The company is also developing AeroVanc, an inhaled vancomycin that is in Phase III development stage for the treatment of methicillin-resistant Staphylococcus aureus lung infection in individuals living with cystic fibrosis. Savara Inc. is headquartered in Austin, Texas.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Pauls Matthew	CHIEF EXECUTIVE OFFICER	Feb 22	Buy	1.74	28,700	50,038	256,622	Feb 23 09:48 AM
Elam Nevan C	Director	Dec 15	Option Exercise	0.52	2,930	1,524	24,612	Dec 17 12:13 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience